Many of the current treatments for rheumatoid arthritis have serious side effects. Recently, researchers tested a new drug combination to see if a one-two-three punch could reduce rheumatoid arthritis's painful symptoms.

Seeing that many rheumatoid arthritis patients don't respond to the leading treatments, researchers found a new way to predict how different patients can be treated.

Treating the symptoms of rheumatoid arthritis is one thing, but researchers may have gone one step further with the discovery of a protein that could potentially reverse pre-existing damage.

Lab tests alone cannot diagnose arthritis in children, additional information about the child is needed to effectively identify the disease.

It's unlikely that any patient who suffers from painful rheumatoid arthritis won't seek treatment for it. However, new research indicates that getting treatment earlier results in improved remission of the disease.

Researchers hope discovery into enzymes, immune cells, and inflammation will alleviate rheumatoid arthritis (RA) and other autoimmune diseases.

According to a new study there are two factors that may cause this group of people to be more likely to become depressed.

If you have rheumatoid arthritis (RA) and poor sleep quality, you may also be at risk for a number of other ailments.

Researchers from the National Institutes of Health have identified a new, extremely rare vascular disease and its genetic cause.

Even though pediatric lupus patients are at increased risk of developing heart disease as adults, statin drugs, which lower cholesterol, do not provide enough benefit to warrant use in these patients. Children with lupus, an autoimmune disease that causes widespread inflammation and organ damage, often exhibit early signs of atherosclerosis (hardening of the arteries) putting them at risk of heart attack and stroke. Researchers at Duke University Medical Center wanted to find a way to lower this risk and turned to statin drugs for the study. The randomized trial included 221 partici...